Influx Healthtech Limited (NSE:INFLUX)

Market Cap	4.97B
Revenue (ttm)	1.24B +62.5%
Net Income	177.56M +146.7%
EPS	9.11 +130.0%
Shares Out	23.15M
PE Ratio	23.56
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,600
Average Volume	32,970
Open	222.00
Previous Close	225.65
Day's Range	214.00 - 227.95
52-Week Range	120.00 - 261.95
Beta	n/a
RSI	49.13
Earnings Date	Jun 11, 2026

About Influx Healthtech

Influx Healthtech Limited operates as a contract development and manufacturing organization that provides a range of healthcare products in India. The company offers ayurvedic and herbal formulations in form of tablets, capsules, powders, liquid orals, ointments, creams, lotions, and other applications; veterinary feed supplements in form of tablets, liquid orals, oral sprays, powders, bolus, gels, ointments, and creams for animals; and home care products, including bathroom cleaners, floor cleansers, phenyle liquids, and other household cleani...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2003
• Employees: 163
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INFLUX

Financial Performance

In fiscal year 2025, Influx Healthtech's revenue was 1.05 billion, an increase of 4.89% compared to the previous year's 999.65 million. Earnings were 133.66 million, an increase of 20.11%.